Immucell ICCC
NASDAQ ICCC
$10.25 -0.14 (-1.35%)
As of: Oct 23, 2026 · 3:21 PM EDT

Immucell (ICCC) Change in Acquisitions & Divestments (2019 - 2021)

Updated

Immucell's Change in Acquisitions & Divestments came in at -$996,000 for FY2021, compared with -$3.45 million in FY2020.

Analysis

Immucell (ICCC) Change in Acquisitions & Divestments (2019 - 2021) Analysis & Trends

  • Per Business Quant, earlier years put Change in Acquisitions & Divestments at -$3.45 million in FY2020 and -$7.67 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Immucell 92.91 Mn 70.36 Mn 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 996,000.00
Dec 31, 2020 996,000.00
Sep 30, 2020 1.99 Mn
Jun 30, 2020 -1.50 Mn
Mar 31, 2020 1.97 Mn
Dec 31, 2019 4.69 Mn
Sep 30, 2019 11.61 Mn
API Access

Immucell Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=ICCC&period=max&api_key=YOUR_API_KEY